As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- Breast cancer survivor Ericka Hart does self-exam on Instagram while dancing to 'Big Ole Freak'on August 16, 2019 at 11:26 am
Her caption reads, “I found out I had breast cancer after doing self-exams since I was 13. I only noticed something felt suspicious because I had been doing them for so long.” She found a lump and was ...
- Chefs break taboo and talk openly about breast canceron August 16, 2019 at 10:00 am
As for me, I wish I didn’t know what breast cancer is like because to be frank, the entire experience of having this disease, and even the long lingering side effects, decimated me in so many ways.
- 7 Unusual Symptoms Of Breast Cancer Doctors Say You Shouldn’t Ignoreon August 16, 2019 at 8:58 am
Whether you have a family history of breast cancer or just make sure you do a breast check every now and then, you're likely aware of the main symptom of breast cancer: a lump or a mass in the breast.
- Breast Cancer Gene Mutation Also Increases Risk Of A Type Of Childhood Cancer, Says New Studyon August 16, 2019 at 8:35 am
As well as this, links have also been shown to both breast and prostate cancer ... irrespective of the childhood lymphoma diagnosis," said Joy Larsen Haidle, genetic counselor at North Memorial Health ...
- Nordic walking may benefit breast cancer patientson August 16, 2019 at 8:00 am
In eight of the nine studies, Nordic walking had a positive effect on a number of breast cancer symptoms, including lymphedema, fitness, upper-body strength, disability and perceptions of pain and ...
- Julia Louis-Dreyfus 'howled with laughter and cried hysterically' after cancer diagnosison August 16, 2019 at 3:00 am
In 2017, the morning after the Emmy Awards - where she picked up prizes for producing and starring in 'Veep' - Julia, 58, received a call from her doctor, informing her that she had breast cancer and ...
- Olivia Newton-John gives update on breast cancer diagnosison August 15, 2019 at 5:45 am
Actress and singer Olivia Newton-John, who revealed last year she was diagnosed with breast cancer, spoke to the press at a cancer benefit about how’s she been doing.Aug. 15, 2019 ...
- U.S. obesity epidemic may be causing cancer rates to riseon August 14, 2019 at 2:28 pm
"The development of cancer from mutation to diagnosis is a 10- to 20-year process," roughly ... RELATED Red meat linked to higher risk of breast cancer On the list of obesity-linked cancers are ...
- BH90210’s Shannen Doherty Says She’s Still Learning to Accept Her Body Post-Breast Canceron August 14, 2019 at 6:30 am
Diagnosed with breast cancer in March 2015, Doherty initially underwent hormone therapy before ultimately undergoing a mastectomy, followed by brutal back-to-back rounds of chemo and radiation.
via Bing News